Cannabis Drug Interactions Every Patient Needs to Know

Cannabis interacts with a significant number of commonly prescribed medications, primarily through its effects on the cytochrome P450 (CYP450) enzyme system — the family of liver enzymes responsible for metabolizing most pharmaceutical drugs. Both THC and CBD inhibit several CYP450 enzymes, which means they can increase blood levels of medications that are metabolized by those enzymes, potentially causing toxicity. Understanding these interactions is essential for any medical cannabis patient who takes other medications.

CBD is a potent inhibitor of CYP2C9 and CYP3A4 — two of the most important drug-metabolizing enzymes in the body. CYP3A4 alone is responsible for metabolizing approximately 50% of all pharmaceutical drugs. When CBD inhibits CYP3A4, drugs that are normally broken down by this enzyme accumulate to higher levels in the blood. This is the same mechanism by which grapefruit interacts with medications — and the warning "do not take with grapefruit" is a useful proxy for "may interact with CBD."

Blood thinners are the highest-priority interaction to discuss with your physician. Warfarin (Coumadin) is metabolized by CYP2C9, which CBD inhibits. Multiple case reports have documented significantly elevated INR (a measure of blood-thinning effect) in patients who added CBD to their warfarin regimen. Elevated INR increases bleeding risk. If you take warfarin and use cannabis, your INR must be monitored more frequently, and your warfarin dose may need to be reduced.

Antiepileptic drugs have complex interactions with cannabis. Epidiolex (pharmaceutical CBD) is FDA-approved for two rare epilepsy syndromes, but it interacts with several antiepileptic medications. CBD increases blood levels of clobazam (Onfi) and its active metabolite, which can cause excessive sedation. CBD also interacts with valproate, potentially increasing liver enzyme levels. Patients using cannabis for epilepsy should have their antiepileptic drug levels monitored regularly.

Immunosuppressants used after organ transplants — particularly tacrolimus and cyclosporine — are metabolized by CYP3A4 and have narrow therapeutic windows. Small changes in blood levels can cause either rejection (too low) or toxicity (too high). Cannabis use in transplant patients has been associated with elevated tacrolimus levels in case reports. Transplant patients should discuss cannabis use with their transplant team before starting.

Antidepressants and anxiolytics have multiple potential interactions. SSRIs and SNRIs may interact with cannabis through serotonin system effects — both cannabis and these medications affect serotonin signaling, and the combination can occasionally cause serotonin syndrome in susceptible individuals. Benzodiazepines (Xanax, Valium, Klonopin) are metabolized by CYP3A4 and may accumulate to higher levels with concurrent CBD use, increasing sedation and respiratory depression risk.

Opioid interactions are complex and clinically important. Cannabis and opioids both have analgesic effects, and some research suggests they work synergistically — meaning lower doses of each may be needed when used together. However, both substances cause respiratory depression, and the combination increases this risk. The clinical evidence on cannabis as an opioid-sparing agent is promising but not yet definitive. Patients who use both should do so under medical supervision.

Statins (cholesterol medications) including atorvastatin (Lipitor) and simvastatin are metabolized by CYP3A4. CBD inhibition of this enzyme can increase statin blood levels, potentially increasing the risk of muscle damage (myopathy) and liver toxicity. If you take a statin and use cannabis regularly, discuss this with your prescribing physician.

The practical approach: before starting medical cannabis, give your physician a complete list of all your medications and ask specifically about CYP450 interactions. Use the lowest effective dose of cannabis to minimize interaction risk. If you notice any new or unusual symptoms after starting cannabis — increased sedation, unusual bleeding, muscle pain, or changes in how your other medications feel — contact your physician promptly. Regular monitoring of relevant lab values (INR for warfarin, drug levels for antiepileptics and immunosuppressants) is essential for patients on these medications.